Epithelial ovarian cancer at a cancer hospital in a developing country

Asian Pacific Journal of Cancer Prevention

Volumn 7, Issue 4, 2006, Pages 595-598

  Shahbaz Sarwar, C M ^a   Siddiqui, Neelam ^a   Khokhar, Rizwan Anwar ^a   Badar, Farhana ^a  

^a SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

Author keywords

Epithelial ovarian cancer; Pakistan; Tertiary care cancer hospital

Indexed keywords

AGE; ARTICLE; CANCER STAGING; CARCINOMA; DEVELOPING COUNTRY; FEMALE; HUMAN; MIDDLE AGED; OVARY TUMOR; PAKISTAN; PATHOLOGY; RISK FACTOR;

AGE FACTORS; CARCINOMA; DEVELOPING COUNTRIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PAKISTAN; RISK FACTORS;

EID: 33947534533     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Ahmad Z, Kayani N, Hasan SH, Muzaffar S, Gill MS (2000). Histological pattern of ovarian neoplasma. J Pak Med Assoc, 50, 416-9.
2. Alam I, Waqar F, Khan A, Begum N (2001). Prevalence and management of ovarian tumors in Women and Children Hospital, Abbottabad. J Ayub Med Coll Abbottabad, 13, 19-21.
3. Arai M, Utsunomiya J, Miki Y (2004). Familial breast and ovarian cancers. Int J Clin Oncol, 9, 270-82.
4. Aziz Z, Sana S, Saeed S, Akram M (2003). Institution based tumor registry from Punjab: five year data based analysis. J Pak Med Assoc, 53, 350-3.
5. Baig LA, Karim SA (2006). Age at menopause, and knowledge of and attitudes tomenopause, of women in Karachi, Pakistan. J Br Menopause Soc, 12, 71-74.
6. Bhoola S, Hoskins WJ (2006). Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol, 107, 1399-410.
7. Christie M, Oehler MK (2006). Molecular pathology of epithelial ovarian cancer. J Br Menopause Soc, 12, 57-63.
8. Fitch MI, Turner F (2006). Ovarian cancer. Cancer Nurse, 102, 16-20.
9. Gatphoh ED, Darnal HK (1990). Pattern of ovarian neoplasm in Manipur. J Indian Med Assoc, 88, 338-9.
10. Guppy AE, Nathan PD, Rustin GJ (2005). Epithelial ovarian cancer: a review of current management. Clin Oncol (R Coll Radiol),17, 399-411.
11. Jacobs IJ, Menon U (2004). Progress and challenges in screening for early detection of ovarian cancer. Mol Cell Proteomics, 3, 355-66.
12. Jones MB (2006). Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol, 49, 517-25.
13. Kauff ND, Satagopan JM, Robson ME, Offit K (2002). Riskreducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med, 346, 1609-15.
14. Liede A, Malik IA, Aziz Z, et al. (2002). Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genetics, 71, 595-606.
15. Malik IA (2002). A prospective study of clinico-pathological features of epithelial ovarian cancer in Pakistan. J Pak Med Assoc, 52, 155-8.
16. Markman M (2006). Unresolved issues in the chemotherapeutic management of gynecologic malignancies. Semin Oncol, 33 (2 Suppl 6), S33-8.
17. Morrison J (2005). Advances in the understanding and treatment of ovarian cancer. J Br Menopause Soc, 11, 66-71.
18. Muzaffar M, Malik IA, Ashraf S (1987). A clinicopathological study of 107 ovarian tumors. J Pak Med Assoc, 37, 194-7.
19. Saeed M, Khawaja K, Rizwan I, et al. (1991) Clinicopathological analysis of ovarian tumors. J Pak Med Assoc, 41, 161-64.
20. Sood AK, Abu-Rustum NR, Gershenson DM (2005). Fifth International Conference on Ovarian Cancer: challenges and opportunities. Gynecol Oncol, 97, 916-23.
21. Tyagi SP, Maheswari V, Tyagi N, et al. (1993). Solid tumors of the ovary. J Indian Med Assoc, 91, 227-30.
22. WHO Histologic Classification of Ovarian Tumors, Geneva, WHO, 1995
23. Yamashita Y, Sagawa T, Fujimoto T, et al. (1999). BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening. Breast Cancer Res Treat, 58, 11-7.
24. Zhang M, Lee AH, Binns CW, Xie X (2004). Green tea consumption enhances survival of epithelial ovarian cancer. Int J Cancer, 10, 465-9.